Main Article Content


Metaplastic carcinoma is a diverse subgroup of invasive breast cancer (IBC) characterised by differentiation of the neoplastic epithelium into squamous cells and/or mesenchymal-looking components, such as but not limited to spindle, chondroid and osseous cells. [1] The clinical characteristics are comparable to those of ER-negative IBC of no special type (NST), although they are more likely to present at an advanced stage. The aetiology is complicated and doesn't seem to be different from IBC-NST (especially the triple-negative subtype). [2] They account for 0.2-1 % of all IBCs. This variation in prevalence stems from the different definitions of metaplastic carcinoma used by different authors.

Article Details

How to Cite
Kumaran Chinnappa, & Sangeetha N. (2023). Metaplastic Carcinoma Masquerading as Tuberculous Mastitis – An Interesting Case Report. Journal of Evolution of Medical and Dental Sciences, 12(9), 294–296.


  1. Hasdemir O, Tokgöz S, Köybaşioğlu F, et al. Clinicopathological features of metaplastic breast carcinoma. Adv Clin Exp Med 2018;27(4):509-13.
  2. Jagtap SV, Bhosale SJ, Kshirsagar AY, et al. Matrix-producing metaplastic breast carcinoma - a rare malignancy. Am J Case Rep 2013;14:213-5.
  3. Cha N, Wang S, Lv M, et al. breast metaplastic squamous cell carcinoma diagnosed with fine needle and core biopsy: a case study. Am J Case Rep 2018;19:203-6.
  4. WHO classification of tumours editorial board: breast tumours. 5th edn. Lyon, France: International Agency for Research on Cancer 2022.
  5. Toumi Z, Bullen C, Tang ACS, et al. Metaplastic breast carcinoma: a case report and systematic review of the literature. Pathol Int 2011;61(10):582-8.
  6. Bigotti G, Di Filippo S, Di Filippo F, et al. An unusual case of metaplastic breast carcinoma following neoadjuvant chemotherapy. Pathol Int 2012;62(1):72-4.